Measles resurgence raises stakes for laboratory testing and surveillance
The United States officially lost its measles elimination status, a status held since 2000, according to CBS News and KFF Health News. The official announcement from PAHO is expected today. For clinical laboratories, this means timely diagnosis and surveillance is more important than ever.
The Centers for Disease Control and Prevention (CDC) still recommends serology and real-time RT-PCR for measles detection. The agency said that nasopharyngeal or throat swabs are preferred over urine samples. Specimen collection and shipping instructions remain the same.
The College of American Pathologists (CAP) launched a Measles, Mumps, Rubella and Varicella-Zoster Virus (MMRV) Molecular Proficiency Testing program in August. CAP advocates for molecular testing because it “detects the virus directly and can distinguish between vaccine-related reactions and true infection.” The program aims to help laboratories prepare for future outbreaks, manage testing demand, enhance testing accuracy and performance, and deliver timely results.
Measles cases in the United States have jumped more than sixty-fold since 2000. As of November 13, there have been 5,412 confirmed cases of measles in the United States in 2026. This is more than double the 2025 number. Measles deaths and hospitalizations are double their 2025 number, and 96% of measles cases are in unvaccinated individuals or individuals that don’t know their vaccination status.
The CDC updated its Be Ready for Measles Toolkit in August. The toolkit provides resources to state and local health departments for measles education and response, including:
- Measles fact sheets
- Vaccine promotion materials
- Awareness graphics to post on social media
- Educational videos
CDC Director, Erica Schwartz, told Reuters on November 10 that there are no plans to change U.S. measles response upon losing elimination status.
An August 2026 literature review revealed the financial burden of measles, stating:
- On average, each case in a measles outbreak costs about $43,203.65.
- Cost per case rises to about $58,591.50 when accounting for the cost of public health response.
- The researchers averaged measles cost per contact at $443.46.
- Initiating public health response to a measles outbreak costs about $297,746.94, with each additional case costing about $16,299.64.
A CIDRAP article pointed out that Brazil regained its elimination status in 2024 after five years, so the U.S. can find its way back to elimination status, but vaccination is key.
About the Author
Erin BradyRelated
adobestock_1127892852
adobestock_972416821